FDA Approves Fluticasone Furoate, Umeclidinium, Vilanterol for Treatment of Asthma
September 14th 2020The triple combination therapy is the first single inhaler triple therapy approved for both asthma and COPD and is the only single inhaler triple therapy available as a once-daily inhalation.
Read More
Coordinated Approach Needed to Increase Follow-Up Care After Rapid HIV, HCV Testing
September 14th 2020Successfully implementing HIV and hepatitis C testing at drug detoxification centers could help identify and link patients to care, but would require that the test results are available to nearby health care facilities.
Read More
Effects of the COVID-19 Pandemic Will Have a Significant Impact on 2021 Drug Spending
September 11th 2020Pharmacy Times® interviewed Steven Lucio, vice president of Pharmacy Solutions at Vizient, on the ways that the COVID-19 pandemic has affected hospital spending this year, which is projected to result in increased drug spending for 2021.
Watch
Significant Provider Relief Fund Updates: Expanded Eligibility and a Reporting Update
September 11th 2020The terms of participation in the phase 2 round of the Provider Relief Fund created an unintended exclusion for pharmacies that primarily serve Medicaid/Children’s Health Insurance Program patients.
Read More
Clinical Features of COVID-19 Versus Seasonal Influenza A, B in US Children
September 11th 2020A new study published in JAMA suggests that prevention of both coronavirus disease 2019 (COVID-19) and seasonal influenza in US children is sensible and important for the well-being of the population.
Read More
Fostering Rapid Innovation During a Time of Crisis
Promoting an environment that allows for rapid problem-solving and execution under high stress is essential to face problems that are poorly understood and yet require rapid change.
Read More